Ampio Pharmaceuticals, Inc.
已退市CIK 1411906fmd_05RTPTW8757C2TGQHJ0PAMWP6Y制造业 · 医药制剂模板: 标准
覆盖范围: 2009年1月01日 至 2023年12月31日，共 56 个期间
| 项目 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 0 | 1 | – | – | – | – | – | – | – | – |
| 净利息收入 | 0 | (0) | – | – | – | – | – | – | – | – |
| 营业成本 | – | 0 | – | – | – | – | – | – | – | – |
| 毛利润 | – | 1 | – | – | – | – | – | – | – | – |
| 研发费用 | 22 | 15 | 11 | – | 7 | 13 | 9 | 12 | 9 | 2 |
| 销售、一般及管理费用 | 12 | 15 | – | – | – | – | – | – | – | – |
| 营业费用合计 | 31 | 24 | 17 | 16 | 11 | 19 | 16 | 21 | 22 | 10 |
| 营业利润 | (39) | (33) | – | – | – | – | – | – | – | – |
| 利息费用 | – | – | – | – | – | – | – | – | – | – |
| 利息及投资收益 | 0 | – | – | – | – | – | – | – | – | – |
| 其他营业外收入（支出） | 0 | 0 | (2) | (36) | 45 | 5 | (0) | 3 | 6 | 1 |
| 税前利润 | – | – | – | – | – | – | – | – | – | – |
| 所得税费用 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| 持续经营净利润 | (31) | (24) | (19) | (52) | – | – | – | – | – | – |
| 净利润 | (38) | (32) | (19) | (52) | 34 | (14) | (16) | (17) | (16) | (9) |
| 归属于普通股股东的净利润 | – | – | – | – | (11) | (18) | (16) | (21) | (22) | (9) |